PedAM
Pediatric Disease Annotations & Medicines
| Disease | interstitial lung disease |
| Phenotype | C0007131|non-small cell lung cancer |
| Sentences | 6 |
| PubMedID- 25012241 | Background: non-small cell lung cancer (nsclc) patients with interstitial lung disease (ild) need to be approached carefully given the high incidence of pulmonary toxicity. |
| PubMedID- 25563718 | Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease. |
| PubMedID- 22114570 | Erlotinib achieved partial response in a non-small cell lung cancer patient with gefitinib-induced interstitial lung disease. |
| PubMedID- 26288223 | interstitial lung disease (ild) occurs in patients with non-small cell lung cancer receiving egfr inhibitors. |
| PubMedID- 21036764 | Background: since advanced non-small cell lung cancer (nsclc) patients with the interstitial lung disease (ild) have been excluded from clinical trials, it is uncertain whether chemotherapy really provides a benefit to these patients. |
| PubMedID- 23750540 | Crizotinib-induced acute interstitial lung disease in a patient with eml4-alk positive non-small cell lung cancer and chronic interstitial pneumonia. |
Page: 1